methyllycaconitine has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, X; Cheng, Z; De-Pu, Z; Guang-Yi, C; Jia, L; Jia-Feng, L; Li-Sha, G; Maoping, C; Wen-Wu, Z; Xiaohong, G; Yue-Chun, L | 1 |
| Liu, Y; Su, DM; Wang, H; Wang, RH; Wang, Y | 1 |
2 other study(ies) available for methyllycaconitine and Acute Disease
| Article | Year |
|---|---|
The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4
Topics: Aconitine; Acute Disease; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cholinergic Agents; Coxsackievirus Infections; Flow Cytometry; Inflammation; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Nicotine; Nicotinic Antagonists; Spleen; Th1 Cells; Th17 Cells | 2018 |
Antinociceptive effects of choline against acute and inflammatory pain.
Topics: Aconitine; Acute Disease; alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Atropine; Bungarotoxins; Central Nervous System; Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Inflammation; Mice; Morphine; Muscarinic Antagonists; Nicotinic Antagonists; Nociceptors; Pain; Pain Measurement; Reaction Time; Receptors, Nicotinic | 2005 |